percent of the world’s Alzheimer’s disease and de-
mentia cases. 
(7) Every year, Alzheimer’s disease and demen-
tia costs the global economy more than $1.3 trillion 
and this is doubling every decade. 
(8) By 2050, the number of Americans living 
with Alzheimer’s disease and dementia is expected to 
reach 12.7 million, bringing the total cost to nearly 
$1 trillion each year. 
(9) Women are disproportionately affected by 
Alzheimer’s disease and dementia, both directly and 
indirectly. Women experience higher disability-ad-
justed life years and mortality due to Alzheimer’s 
disease and dementia, but also provide 70 percent of 
care hours for people living with Alzheimer’s disease 
and dementia. 
(10) The Davos Alzheimer’s Collaborative 
(DAC) is a public–private–patient venture, launched 
in 2021, that is transforming Alzheimer’s disease 
and dementia research, prevention, and care in low- 
income, middle-income, and high-income settings 
globally. 
(11) DAC seeks to raise and deploy over $700 
million over 6 years to accelerate innovation in drug 
development and transform the way healthcare sys-
VerDate Sep 11 2014 
03:01 Nov 21, 2024
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H10175.IH
H10175
ssavage on LAPJG3WLY3PROD with BILLS
tems prevent, diagnose, and treat Alzheimer’s dis-
ease and dementia for all people in all places. 
(12) In 2023, DAC supported 19 healthcare 
systems in 12 countries, including the United States. 
(13) The United States Government is the larg-
est funder of global health programs, with approxi-
mately $12 billion in annual funding for programs 
that cover the full range of global health challenges. 
(14) USAID and the Department of State are 
lead funders of multilateral health initiatives, such 
as Gavi, the Vaccine Alliance, the Global Fund to 
Fight AIDS, TB and Malaria, the Coalition for Epi-
demic Preparedness Innovations, and the Inter-
national AIDS Vaccine Initiative. 
SEC. 3. STATEMENT OF POLICY. 
It shall be the policy of the United States— 
(1) to lead global cooperative efforts to combat 
Alzheimer’s disease and dementia, including in coun-
tries with low-income economies and countries with 
middle-income economies (as such terms are defined 
by the World Bank) that represent the majority of 
future cases; and 
(2) to lead multilateral health initiatives, in-
cluding the Davos Alzheimer’s Collaborative— 
VerDate Sep 11 2014 
03:01 Nov 21, 2024
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H10175.IH
H10175
ssavage on LAPJG3WLY3PROD with BILLS
(A) to develop diagnostics and treatments 
for diverse populations in the United States and 
across the globe; 
(B) to promote international development 
cooperation; and 
(C) to provide substantial leverage and 
burden sharing for United States investments. 
SEC. 4. AUTHORIZATION FOR UNITED STATES PARTICIPA-
TION IN THE DAVOS ALZHEIMER’S COLLABO-
RATIVE. 
(a) IN GENERAL.—The United States is hereby au-
thorized to participate in, and contribute to, the Davos 
Alzheimer’s Collaborative (DAC) in order to advance 
international efforts to prevent, diagnose, and treat Alz-
heimer’s disease and dementia. 
(b) DESIGNEE.— 
(1) IN GENERAL.—The President is authorized 
to designate an employee of the relevant Federal de-
partment or agency providing the majority of United 
States contributions to DAC to serve on the Advi-
sory Council of DAC and, if nominated, on the 
Board of Directors of DAC, as a representative of 
the United States. 
(2) QUALIFICATIONS.—The individual to be 
designated pursuant to paragraph (1) should dem-
VerDate Sep 11 2014 
03:01 Nov 21, 2024
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H10175.IH
H10175
ssavage on LAPJG3WLY3PROD with BILLS
onstrate knowledge and experience in the fields of 
development and public health. 
(3) COOPERATION.—In carrying out this sec-
tion, the individual designated pursuant to para-
graph (1) shall coordinate with the USAID Adminis-
trator, the Secretary of State, and the Secretary of 
Health and Human Services to promote alignment, 
as appropriate, between DAC and United States 
global health and Alzheimer’s disease and dementia 
research and development programs. 
(c) UNITED STATES CONTRIBUTIONS.— 
(1) IN GENERAL.—Amounts authorized to be 
appropriated and made available to carry out chap-
ters 1 and 10 of part I and chapter 4 of part II of 
the Foreign Assistance Act of 1961 (22 U.S.C. 2151 
et seq.) are authorized to be made available for 
United States contributions to DAC. 
(2) MATCHING REQUIREMENT.—Amounts made 
available under paragraph (1) may be obligated and 
expended only to the extent that DAC secures fund-
ing from sources other than the United States. At 
any time during fiscal years 2025 through 2029, no 
United States contribution to DAC may cause the 
total amount of United States Government contribu-
tions to DAC to exceed 33 percent of the total 
VerDate Sep 11 2014 
03:01 Nov 21, 2024
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H10175.IH
H10175
ssavage on LAPJG3WLY3PROD with BILLS
amount of funds contributed to the DAC from all 
sources. 
(d) REPORT.—Not later than 180 days after the date 
of the enactment of this Act, and on an annual basis there-
after, the President shall submit to the appropriate con-
gressional committees a report that includes the following: 
(1) A description of any planned financial con-
tributions from the United States Government to 
DAC. 
(2) The manner and extent to which the United 
States will participate in the governance of DAC. 
(3) A summary of private and governmental 
contributions to DAC. 
(4) A description of how participation in DAC 
supports relevant United States Government strate-
gies and programs to combat Alzheimer’s disease 
and dementia and to promote global health. 
(e) DEFINITION.—In subsection (d), the term ‘‘ap-
propriate congressional committees’’ means— 
(1) the Committee on Foreign Affairs and Com-
mittee on Appropriations of the House of Represent-
atives; and 
(2) the Committee on Foreign Relations and 
the Committee on Appropriations of the Senate. 
Æ 
VerDate Sep 11 2014 
03:01 Nov 21, 2024
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H10175.IH
H10175
ssavage on LAPJG3WLY3PROD with BILLS